Logo image of Z

ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:Z - US98954M2008 - Common Stock

67.89 USD
+0.34 (+0.5%)
Last: 1/15/2026, 4:21:32 PM
67.01 USD
-0.88 (-1.3%)
After Hours: 1/15/2026, 4:21:32 PM
Fundamental Rating

5

Z gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. While Z has a great health rating, there are worries on its profitability. Z is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • Z had positive earnings in the past year.
  • Z had a positive operating cash flow in the past year.
  • Z had negative earnings in each of the past 5 years.
  • Z had a positive operating cash flow in 4 of the past 5 years.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.56%, Z is in line with its industry, outperforming 47.62% of the companies in the same industry.
  • The Return On Equity of Z (-0.64%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

  • Looking at the Gross Margin, with a value of 74.87%, Z belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
  • In the last couple of years the Gross Margin of Z has grown nicely.
  • The Profit Margin and Operating Margin are not available for Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

  • Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Z has more shares outstanding than it did 1 year ago.
  • Z has more shares outstanding than it did 5 years ago.
  • Z has a better debt/assets ratio than last year.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • Z has an Altman-Z score of 14.15. This indicates that Z is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of Z (14.15) is better than 90.48% of its industry peers.
  • Z has a debt to FCF ratio of 1.83. This is a very positive value and a sign of high solvency as it would only need 1.83 years to pay back of all of its debts.
  • Z has a better Debt to FCF ratio (1.83) than 85.71% of its industry peers.
  • Z has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • Z has a Debt to Equity ratio of 0.05. This is in the better half of the industry: Z outperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Altman-Z 14.15
ROIC/WACCN/A
WACC8.41%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

  • Z has a Current Ratio of 3.63. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.63, Z is doing good in the industry, outperforming 79.37% of the companies in the same industry.
  • Z has a Quick Ratio of 3.63. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
  • Z has a better Quick ratio (3.63) than 82.54% of its industry peers.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 3.63
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • Z shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.92%, which is quite good.
  • The Revenue has grown by 15.17% in the past year. This is quite good.
  • Z shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%

3.2 Future

  • Based on estimates for the next years, Z will show a very strong growth in Earnings Per Share. The EPS will grow by 30.58% on average per year.
  • Z is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.16% yearly.
EPS Next Y23.24%
EPS Next 2Y28.2%
EPS Next 3Y30.34%
EPS Next 5Y30.58%
Revenue Next Year15.85%
Revenue Next 2Y15.16%
Revenue Next 3Y14.6%
Revenue Next 5Y14.16%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

  • Z is valuated quite expensively with a Price/Earnings ratio of 44.66.
  • Compared to the rest of the industry, the Price/Earnings ratio of Z indicates a somewhat cheap valuation: Z is cheaper than 66.67% of the companies listed in the same industry.
  • Z's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.33.
  • The Price/Forward Earnings ratio is 30.15, which means the current valuation is very expensive for Z.
  • Based on the Price/Forward Earnings ratio, Z is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.12. Z is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 44.66
Fwd PE 30.15
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Z's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 63.49% of the companies in the same industry are more expensive than Z, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 110.29
EV/EBITDA 83.51
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • Z's earnings are expected to grow with 30.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.92
PEG (5Y)N/A
EPS Next 2Y28.2%
EPS Next 3Y30.34%

0

5. Dividend

5.1 Amount

  • Z does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ZILLOW GROUP INC - C

NASDAQ:Z (1/15/2026, 4:21:32 PM)

After market: 67.01 -0.88 (-1.3%)

67.89

+0.34 (+0.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-30
Earnings (Next)02-09
Inst Owners99.3%
Inst Owner Change0.29%
Ins Owners6.41%
Ins Owner Change-5.9%
Market Cap16.43B
Revenue(TTM)2.48B
Net Income(TTM)-32.00M
Analysts74.67
Price Target88.74 (30.71%)
Short Float %6.59%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.54%
Min EPS beat(2)-7.26%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-1.47%
Min EPS beat(4)-7.26%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)15.44%
EPS beat(12)10
Avg EPS beat(12)56.38%
EPS beat(16)14
Avg EPS beat(16)88.61%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-0.78%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)-0.3%
Revenue beat(8)4
Avg Revenue beat(8)1.15%
Revenue beat(12)8
Avg Revenue beat(12)2.22%
Revenue beat(16)10
Avg Revenue beat(16)-4.7%
PT rev (1m)0%
PT rev (3m)-1.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.62%
EPS NY rev (1m)0%
EPS NY rev (3m)1.44%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 44.66
Fwd PE 30.15
P/S 6.62
P/FCF 110.29
P/OCF 39.31
P/B 3.29
P/tB 8.67
EV/EBITDA 83.51
EPS(TTM)1.52
EY2.24%
EPS(NY)2.25
Fwd EY3.32%
FCF(TTM)0.62
FCFY0.91%
OCF(TTM)1.73
OCFY2.54%
SpS10.26
BVpS20.62
TBVpS7.83
PEG (NY)1.92
PEG (5Y)N/A
Graham Number26.56
Profitability
Industry RankSector Rank
ROA -0.56%
ROE -0.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.87%
FCFM 6%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.83
Debt/EBITDA 1.57
Cap/Depr 102.28%
Cap/Sales 10.83%
Interest Coverage N/A
Cash Conversion 241.62%
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 3.63
Altman-Z 14.15
F-Score7
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)73.5%
Cap/Depr(5y)73.95%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.71%
EPS Next Y23.24%
EPS Next 2Y28.2%
EPS Next 3Y30.34%
EPS Next 5Y30.58%
Revenue 1Y (TTM)15.17%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%16.35%
Revenue Next Year15.85%
Revenue Next 2Y15.16%
Revenue Next 3Y14.6%
Revenue Next 5Y14.16%
EBIT growth 1Y57.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year433.87%
EBIT Next 3Y94.02%
EBIT Next 5Y58.6%
FCF growth 1Y-21.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.75%
OCF growth 3YN/A
OCF growth 5YN/A

ZILLOW GROUP INC - C / Z FAQ

What is the ChartMill fundamental rating of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a fundamental rating of 5 / 10 to Z.


What is the valuation status of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a valuation rating of 3 / 10 to ZILLOW GROUP INC - C (Z). This can be considered as Overvalued.


What is the profitability of Z stock?

ZILLOW GROUP INC - C (Z) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for Z stock?

The Price/Earnings (PE) ratio for ZILLOW GROUP INC - C (Z) is 44.66 and the Price/Book (PB) ratio is 3.29.


What is the financial health of ZILLOW GROUP INC - C (Z) stock?

The financial health rating of ZILLOW GROUP INC - C (Z) is 8 / 10.